Grover Jewells IPO
IPO, News

Grover Jewells IPO 2026 – Dates, Price Band, Lot Size & Full Review

Incorporated in 2021, Grover Jewells Limited is engaged in the manufacturing and designing of a wide range of wholesale gold jewellery. Grover Jewells IPO 2026 – Dates, Price Band, Lot Size & Full Details Book Built IPO | NSE SME IPO Snapshot IPO Open:4 February 2026 IPO Close:6 February 2026 Allotment:9 February 2026 Listing Date:11 […]

REC Q3 results 2026
Markets, News

Why REC Shares Slipped After Q3 Results: How Flat Profits and ₹4.60 Dividend Impacted the Stock

NEW DELHI – REC Limited, the Maharatna public sector power financier, reported a stable yet muted third-quarter (Q3FY26) performance on Thursday, January 29, 2026. While the company maintained its streak of rewarding shareholders with a third interim dividend, its bottom line faced a “plateau” effect, with net profit remaining virtually flat year-on-year (YoY) and witnessing

Swiggy Q3 results 2026
Markets, News

Why Swiggy’s Loss Stayed Above ₹1,000 Crore: How Instamart Expansion and Competition Impacted Q3 Results

BENGALURU – Hyperlocal delivery giant Swiggy Limited reported a challenging third quarter on Thursday, January 29, 2026, as its consolidated net loss remained above the ₹1,000 crore mark for the second consecutive quarter. While the company achieved a massive 54% surge in revenue, the heavy cost of scaling its quick-commerce arm, Instamart, continues to weigh

India Cements share price target Motilal Oswal
Markets, News

Why Motilal Oswal Issued a ‘Sell’ on India Cements: How a Return to Losses and Valuation Concerns Led to a ₹370 Target

MUMBAI – Domestic brokerage powerhouse Motilal Oswal Financial Services (MOFSL) has reiterated its “Sell” rating on India Cements Ltd (ICL), setting a revised target price of ₹370. The downgrade follows a turbulent third quarter (Q3FY26) for the South-based cement major, where a fragile recovery was derailed by a return to consolidated losses, sparking concerns about

Gland Pharma shares surge 9%
Markets, News

Why Gland Pharma Shares Jumped 9%: How Q3 Profits and US Growth Led the Rally

MUMBAI – Shares of Hyderabad-based Gland Pharma surged over 9% on Thursday, January 29, 2026, hitting an intraday high of ₹1,849 on the National Stock Exchange (NSE). The vertical rally follows the company’s strongest quarterly performance in its history, characterized by a sharp rebound in its core U.S. business and a long-awaited operational turnaround in

Silver price cross 4 lakh India
Markets, News

Silver Price News India: Silver Crosses ₹4 Lakh/kg; Will it Crash Like 1980?

MUMBAI – In an unprecedented move that has rewritten the history of Indian commodity markets, silver futures on the Multi Commodity Exchange (MCX) breached the psychological barrier of ₹4,00,000 per kilogram on Thursday, January 29, 2026. The “white metal” surged over ₹22,000 in a single session, outshining gold and delivering a staggering 73% return in

Scroll to Top